Food Safety and Environmental Testing
  1. Home
  2. Services
  3. Pharmaceutical Quality Control

Product-Specific Validation (PSV) & Interference Resolution

Overcoming matrix interference, endotoxin masking, and false negatives prior to commercial rollout.

 

CellMade delivers comprehensive validation strategies engineered to overcome matrix interference, sample-induced toxicity, and endotoxin masking prior to commercial drug release. Because complex biological formulations often interact with cell-based test systems, our specialized protocols rigorously evaluate drug-cell compatibility, eliminate false-negative risks, and resolve Low Endotoxin Recovery (LER) phenomena. By executing complete three-batch product-specific validations using diverse reference pyrogens, we provide biopharmaceutical innovators with the empirical proof of assay reliability and matrix compatibility required by Ph. Eur. 2.6.30 standards.

 

  • Product-Specific Validation (Ph. Eur. 2.6.30): Full three-batch validation packages that demonstrate matrix compatibility, baseline stability, and reproducible pyrogen detection across representative commercial lots.

  • Low Endotoxin Recovery (LER) & Masking Resolution: Specialized sample preparation and unmasking protocols engineered to restore endotoxin recovery in formulations containing surfactants, chelating agents, or complex protein buffers.

  • Interference & Inhibition Profiling: De-risking drug-cell interactions by systematically screening for intrinsic API toxicity, auto-stimulation, or color/enzymatic interference that could skew colorimetric or fluorometric readouts.

  • RSE & Non-Endotoxin Pyrogen (NEP) Spike Recovery: Broad-spectrum assay verification using Reference Standard Endotoxin (RSE) alongside validated NEP controls (e.g., LTA, Zymosan, Flagellin) to confirm robust immune detection across diverse pyrogen classes.